Fortitude Family Office, LLC Bridge Bio Pharma, Inc. Transaction History
Fortitude Family Office, LLC
- $372 Billion
- Q3 2025
A detailed history of Fortitude Family Office, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 65 shares of BBIO stock, worth $3,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 53
22.64%
Holding current value
$3,989
Previous $2.29 Million
47.49%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
414Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.14 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.01 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$814 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$764 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$569 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...